Description
Ipamorelin 10mg is a lyophilised research-peptide vial with a nominal 10 mg amount. Ipamorelin is a synthetic pentapeptide studied as a growth-hormone secretagogue. Its research mechanism is distinct from GHRH analogues such as CJC-1295 No DAC: the classic pharmacology work places ipamorelin in the GHRP/ghrelin-receptor secretagogue class rather than the GHRH-receptor class.
For in-vitro laboratory research only; not for human or veterinary use.
What the early pharmacology showed
Raun and colleagues described ipamorelin as a pentapeptide and compared its growth-hormone-releasing activity with other secretagogues. In primary rat pituitary cells, ipamorelin produced GH release with potency and efficacy in the same range as GHRP-6 in their assay. Antagonist profiling supported action through a GHRP-like receptor rather than the GHRH receptor. Source.
The study is useful for receptor-class and assay interpretation. It does not establish that a commercial 10 mg vial reproduces every experimental property, nor does it provide a personal-use protocol.
Why receptor distinction matters in combination studies
Ipamorelin and Modified GRF/CJC-1295 No DAC are often discussed together because they interrogate different signalling inputs to growth-hormone release. Evidence for one receptor class cannot be used as identity evidence for the other, and a two-peptide blend requires its own composition and finished-product documentation.
Product identity and documentation
The current catalogue identifies this product as Ipamorelin 10mg in a sealed lyophilised vial. The older page also lists a CAS number, molecular formula and molecular weight; those fields are useful only if they match the exact chemical form in the applicable product specification, so this candidate does not treat the live page alone as independent proof.
No universal purity threshold, identity-test completion or storage interval is inserted without a source applicable to this product/lot. Request batch documentation using Ipamorelin 10mg and the lot/order identifiers where available. Use the CoA-reading guide and mass-spectrometry guide when interpreting the record.
Storage and receiving
Follow the documented conditions for the supplied lyophilised material. At receipt, match the vial, nominal amount and lot against the order and inspect the closure and packaging. Use the receiving checklist and storage-temperature guide.
Related presentations
The CJC-1295 No DAC + Ipamorelin 10mg blend, its refill and pen-format records are separate products. Their combined composition and finished-format evidence should be assessed independently.
Research-use boundary and support
For in-vitro laboratory research only; not for human or veterinary use.
Current price and availability remain in the native purchase panel. Read Testing & Quality Methodology, Shipping & Delivery and the Research Use Only policy.
Selected reference
- Raun K et al. (1998). Ipamorelin, the first selective growth hormone secretagogue. PMID 9849822; DOI 10.1530/eje.0.1390552.
